|
Therapeutic Category |
|
Anti-Lipidemic |
|
Generic Name |
|
Bezafibrate |
|
Indications |
|
It is indicated as adjunctive therapy to diet for the reduction of LDL-C, Total-C, Triglycerides and Apo B in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Type IIa and IIb). Bezafibrate is indicated as adjunctive therapy to diet for the treatment of adult patients with hypertriglyceridemia (Fredrickson types IV and V hyperlipidemia). |
|
Brand Name |
|
Lipocor |
|
Dosage Form |
|
Tablet |
|
Strength |
|
200 mg |
|
Market Availability |
|
Pakistan |
|
Presentation |
|
Alu-Alu strip of 30's |
|
|
|